ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Preclinical

DSIP

DSIP

Also known as: DSIP Recovery Peptide, Delta Sleep Peptide

Overview

Key Facts

Primary Goal: Research and therapeutic applications of DSIP

Modulates GABAergic and glutamatergic neurotransmission. Enhances delta-wave EEG activity during sleep.

Looking for the best price?

Compare live DSIP prices from 8+ verified UK & US suppliers

Compare DSIP prices →
Updated daily · Trusted suppliers

Dosing Information

Half-Life

~15 minutes (rapid enzymatic degradation)

Typical Dose

100–300 mcg

Frequency

1x daily before bed

Cycle Length

2-4 weeks, cycling on/off

Administration Routes:
subcutaneousintramuscular

Benefits

  • Promotes deep restorative delta-wave sleep
  • Enhances overnight recovery and tissue repair
  • Normalizes disrupted sleep patterns
  • Modulates stress response and lowers cortisol
  • May increase growth hormone release during sleep
  • Analgesic properties for chronic pain

Side Effects

Excessive drowsiness if dosed too highmild
Vivid dreamsmild
Morning grogginess (uncommon)mild
Mild headache (rare)mild

Mechanism of Action

1

Modulates GABAergic and glutamatergic neurotransmission

2

Enhances delta-wave EEG activity during sleep

3

Normalizes corticotropin and cortisol secretion patterns

4

Acts on opioid receptors for analgesic effects

5

May interact with serotonin and dopamine pathways

Contraindications

Do not use this peptide if any of the following apply:

  • Concurrent sedative or hypnotic medication use
  • Severe respiratory depression
  • Pregnancy or breastfeeding

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration1-2 weeks

Note: Protect from light. Do not freeze reconstituted solution.

For suppliers & labs

Building a DSIP catalogue? Custom waterproof vial & pen labels (zero MOQ, UK print) on PepPrint →

Research Summary

Preclinical

Discovered in 1977 by Schoenenberger and Monnier. Studied in human trials for insomnia, chronic pain, and withdrawal syndromes with mixed but promising results. Most research from 1980s-1990s European studies. Mechanism remains complex and not fully elucidated.

Frequently Asked Questions

Common questions about DSIP

UK-Specific Information

Exclusive data points and guidance for UK residents using DSIP

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Share on TikTok

Generate a trackable link to share this peptide information on TikTok